Lipodystrophy in HIV patients: its challenges and management approaches
Rohit Singhania, Donald P KotlerDepartment of Medicine, St Luke's-Roosevelt Hospital Center, New York, NY, USAAbstract: HIV-associated lipodystrophy is a term used to describe a constellation of body composition (lipoatrophy and lipohypertrophy) and metabolic (dyslipidemia and insulin re...
Guardado en:
Autores principales: | Singhania R, Kotler DP |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c35a92d4cd4c4daf904767d83e9f1d59 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
New and emerging agents in the management of lipodystrophy in HIV-infected patients
por: Eric Bonnet
Publicado: (2010) -
Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy
por: Bedimo R
Publicado: (2011) -
Managing dyslipidemia in HIV/AIDS patients: challenges and solutions
por: Husain NE, et al.
Publicado: (2014) -
Management of Pneumocystis Jirovecii pneumonia in HIV infected patients: current options, challenges and future directions
por: Jose G Castro, et al.
Publicado: (2010) -
Management of chronic diarrhea in HIV-infected patients: current treatment options, challenges and future directions
por: Lidia Elfstrand, et al.
Publicado: (2010)